1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Renal Insufficiency

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Renal Insufficiency in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Grino, JM	1
Camici, M	1
Civati, G; Gervasio, R; Guastoni, C; Hoenich, NA; Sereni, L; Tessore, E; Tetta, C; Wratten, ML	1
Camici, M; Carpi, A; Sagripanti, A	1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Renal Insufficiency

Article	Year
[Progression of renal insufficiency and platelet activating factor (PAF)]. Minerva medica, 1996, Volume: 87, Issue:6 Topics: Disease Progression; Glomerular Mesangium; Humans; Kidney; Platelet Activating Factor; Renal Insufficiency	1996

Trials

2 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Renal Insufficiency

Article	Year
BN 52021: a platelet activating factor antagonist for preventing post-transplant renal failure. A double-blind, randomized study. The BN 52021 Study Group in Renal Transplantation. Annals of internal medicine, 1994, Sep-01, Volume: 121, Issue:5 Topics: Adult; Aged; Cadaver; Diterpenes; Double-Blind Method; Female; Ginkgolides; Humans; Kidney Transplantation; Lactones; Male; Middle Aged; Pilot Projects; Platelet Activating Factor; Renal Insufficiency	1994
Mechanisms and kinetics of the synthesis and release of platelet-activating factor (PAF) by polyacrylonitrile membranes. Clinical nephrology, 1996, Volume: 46, Issue:2 Topics: Acrylic Resins; Aged; Biocompatible Materials; Complement C3; Complement C5; Complement C5b; Complement C9; Female; Humans; Immunoenzyme Techniques; Leukocyte Count; Magnetic Resonance Spectroscopy; Male; Membranes, Artificial; Middle Aged; Platelet Activating Factor; Platelet Count; Renal Dialysis; Renal Insufficiency	1996

Article

Year

BN 52021: a platelet activating factor antagonist for preventing post-transplant renal failure. A double-blind, randomized study. The BN 52021 Study Group in Renal Transplantation.

Annals of internal medicine, 1994, Sep-01, Volume: 121, Issue:5

Topics: Adult; Aged; Cadaver; Diterpenes; Double-Blind Method; Female; Ginkgolides; Humans; Kidney Transplantation; Lactones; Male; Middle Aged; Pilot Projects; Platelet Activating Factor; Renal Insufficiency

1994

Mechanisms and kinetics of the synthesis and release of platelet-activating factor (PAF) by polyacrylonitrile membranes.

Clinical nephrology, 1996, Volume: 46, Issue:2

Topics: Acrylic Resins; Aged; Biocompatible Materials; Complement C3; Complement C5; Complement C5b; Complement C9; Female; Humans; Immunoenzyme Techniques; Leukocyte Count; Magnetic Resonance Spectroscopy; Male; Membranes, Artificial; Middle Aged; Platelet Activating Factor; Platelet Count; Renal Dialysis; Renal Insufficiency

1996

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Renal Insufficiency

Article	Year
[Platelet activating factor (PAF) and kidney failure progression]. Minerva medica, 1997, Volume: 88, Issue:9 Topics: Blood Coagulation; Disease Progression; Humans; Platelet Activating Factor; Renal Insufficiency	1997